Cargando…
Current advances in gene therapy of mitochondrial diseases
Mitochondrial diseases (MD) are a heterogeneous group of multisystem disorders involving metabolic errors. MD are characterized by extremely heterogeneous symptoms, ranging from organ-specific to multisystem dysfunction with different clinical courses. Most primary MD are autosomal recessive but mat...
Autores principales: | Soldatov, Vladislav O., Kubekina, Marina V., Skorkina, Marina Yu., Belykh, Andrei E., Egorova, Tatiana V., Korokin, Mikhail V., Pokrovskiy, Mikhail V., Deykin, Alexey V., Angelova, Plamena R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724384/ https://www.ncbi.nlm.nih.gov/pubmed/36471396 http://dx.doi.org/10.1186/s12967-022-03685-0 |
Ejemplares similares
-
Correction: Current advances in gene therapy of mitochondrial diseases
por: Soldatov, Vladislav O., et al.
Publicado: (2023) -
Cytokines in Abdominal Aortic Aneurysm: Master Regulators With Clinical Application
por: Puchenkova, Olesya A, et al.
Publicado: (2022) -
P2X7 Receptor and Purinergic Signaling: Orchestrating Mitochondrial Dysfunction in Neurodegenerative Diseases
por: Zelentsova, Alexsandra S., et al.
Publicado: (2022) -
HPRT1 Deficiency Induces Alteration of Mitochondrial Energy Metabolism in the Brain
por: Vinokurov, Andrey Y., et al.
Publicado: (2023) -
Polymorphism of SERF2, the gene encoding a heat-resistant obscure (Hero) protein with chaperone activity, is a novel link in ischemic stroke
por: Belykh, Andrei E., et al.
Publicado: (2023)